Alterations of tumour suppressor gene PPP2R1B in hepatocellular carcinoma

Cancer Letters

Volumn 253, Issue 1, 2007, Pages 138-143

  Chou, Huei Chi ^a   Chen, Chien Hung ^a   Lee, Hsuan Shu ^a   Lee, Cha Ze ^a   Huang, Guan Tarn ^a   Yang, Pei Ming ^a   Lee, Po Huang ^a   Sheu, Jin Chuan ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Aberrant transcript; Hepatocellular carcinoma; PPP2R1B; Protein phosphatase 2A

Indexed keywords

MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PATHOGENESIS; PPP2R1B GENE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE DELETION; GENES, TUMOR SUPPRESSOR; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 34249909523     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.01.016     Document Type: Article

References (27)

1. Beasley R.P. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 61 (1988) 1942-1956
2. D.A. Linsell, J. Higginson, The geographic pathology of liver cell cancer, in: H.M. Cameron, D.A. Linsell, G.P. Warwick (Eds.), Liver cell cancer, New York, 1976, pp. 1-16.
3. Sheu J.C., Huang G.T., Shih L.N., Lee W.C., Chou H.C., Wang J.T., Lee P.H., Lai M.Y., Wang C.Y., Yang P.M., et al. Gastroenterology 103 (1992) 1322-1327
4. Suriawinata A., and Xu R. An update on the molecular genetics of hepatocellular carcinoma. Semin. Liver Dis. 24 (2004) 77-88
5. Baffa R., Negrini M., Mandes B., Rugge M., Ranzani G., Hirohashi S., and Croce C. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 56 (1996) 268-272
6. Chen L., Matsumura K., Deng G., Kurisu W., Ljung B., Lerman M., Waldman F., and Smith H. Deletion of two separate regions on chromosome 3p in breast cancers. Cancer Res. 54 (1994) 3021-3024
7. Jou Y.S., Lee C.S., Chang Y.H., Hsiao C.F., Chen C.F., Chao C.C., Wu L.S., Yeh S.H., Chen D.S., and Chen P.J. Clustering of minimal deleted regions reveals distinct genetic pathways of human hepatocellular carcinoma. Cancer Res. 64 (2004) 3030-3036
8. Lin Y.W., Lee I.N., Chen C.H., Huang G.T., Lee H.S., Lee P.H., Lu F.J., and Sheu J.C. Deletion mapping of chromosome 16q24 in hepatocellular carcinoma in Taiwan and mutational analysis of the 17-beta-HSD gene localized to the region. Int. J. Cancer 93 (2001) 74-79
9. Marsit C.J., Hasegawa M., Hirao T., Kim D.-H., Aldape K., Hinds P.W., Wiencke J.K., Nelson H.H., and Kelsey K.T. Loss of heterozygosity of chromosome 3p21 is associated with mutant TP53 and better patient survival in non-small-cell lung cancer. Cancer Res. 64 (2004) 8702-8707
10. Sheu J.C., Lin Y.W., Chou H.C., Huang G.T., Lee H.S., Lin Y.H., Huang S.Y., Chen C.H., Wang J.T., Lee P.H., Lin J.T., Lu F.J., and Chen D.S. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan. Br. J. Cancer 80 (1999) 468-476
11. Wang S.S., Esplin E.D., Li J.L., Huang L., Gazdar A., Minna J., and Evans G.A. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282 (1998) 284-287
12. Takagi Y., Futamura M., Yamaguchi K., Aoki S., Takahashi T., and Saji S. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers. Gut 47 (2000) 268-271
13. Calin G.A., di Iasio M.G., Caprini E., Vorechovsky I., Natali P.G., Sozzi G., Croce C.M., Barbanti-Brodano G., Russo G., and Negrini M. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms. Oncogene 19 (2000) 1191-1195
14. Zhu Y., Loukola A., Monni O., Kuokkanen K., Franssila K., Elonen E., Vilpo J., Joensuu H., Kere J., Aaltonen L., and Knuutila S. PPP2R1B gene in chronic lymphocytic leukemias and mantle cell lymphomas. Leuk. Lymphoma 41 (2001) 177-183
15. Mumby M.C., and Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol. Rev. 73 (1993) 673-699
16. Walter G., and Mumby M. Protein serine/threonine phosphatases and cell transformation. Biochim. Biophys. Acta 1155 (1993) 207-226
17. Lee T.H., Solomon M.J., Mumby M.C., and Kirschner M.W. INH, a negative regulator of MPF, is a form of protein phosphatase 2A. Cell 64 (1991) 415-423
18. Harmala-Brasken A.S., Mikhailov A., Soderstrom T.S., Meinander A., Holmstrom T.H., Damuni Z., and Eriksson J.E. Type-2A protein phosphatase activity is required to maintain death receptor responsiveness. Oncogene 22 (2003) 7677-7686
19. Li H., Zhao L.L., Funder J.W., and Liu J.P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 272 (1997) 16729-16732
20. Baysal B.E., Farr J.E., Goss J.R., Devlin B., and Richard III C.W. Genomic organization and precise physical location of protein phosphatase 2A regulatory subunit A beta isoform gene on chromosome band 11q23. Gene 217 (1998) 107-116
21. Wu R., Connolly D.C., Ren X., Fearon E.R., and Cho K.R. Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas. Neoplasia 1 (1999) 311-314
22. Campbell I.G., and Manolitsas T. Absence of PPP2R1B gene alterations in primary ovarian cancers. Oncogene 18 (1999) 6367-6369
23. Negrini M., Monaco C., Vorechovsky I., Ohta M., Druck T., Baffa R., Huebner K., and Croce C.M. The FHIT gene at 3p14.2 is abnormal in breast carcinomas. Cancer Res. 56 (1996) 3173-3179
24. Ahmadian M., Wistuba II, Fong K.M., Behrens C., Kodagoda D.R., Saboorian M.H., Shay J., Tomlinson G.E., Blum J., Minna J.D., and Gazdar A.F. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Cancer Res. 57 (1997) 3664-3668
25. Hayashi S., Tanimoto K., Hajiro-Nakanishi K., Tsuchiya E., Kurosumi M., Higashi Y., Imai K., Suga K., and Nakachi K. Abnormal FHIT transcripts in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res. 57 (1997) 1981-1985
26. Ingvarsson S. FHIT alterations in breast cancer. Semin. Cancer Biol. 11 (2001) 361-366
27. Kastury K., Baffa R., Druck T., Ohta M., Cotticelli M.G., Inoue H., Negrini M., Rugge M., Huang D., Croce C.M., Palazzo J., and Huebner K. Potential gastrointestinal tumor suppressor locus at the 3p14.2 FRA3B site identified by homozygous deletions in tumor cell lines. Cancer Res. 56 (1996) 978-983